Osteoporosis and Enlarged heart
Summary:
Enlarged heart is found among people with Osteoporosis, especially for people who are female, 60+ old.
The study analyzes which people have Enlarged heart with Osteoporosis. It is created by eHealthMe based on reports of 700 people who have Osteoporosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
700 people who have Osteoporosis and Enlarged Heart are studied.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 2,629 drugs and 1,865 conditions by eHealthMe.
What is Enlarged heart?
Enlarged heart is found to be associated with 2,401 drugs and 1,611 conditions by eHealthMe.
Number of Enlarged heart in Osteoporosis reports submitted per year:
Gender of people who have Osteoporosis and experienced Enlarged heart *:
Age of people who have Osteoporosis and experienced Enlarged heart *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Enlarged heart?
Check whether Enlarged heart is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Related studies
Treatments, associated drugs and conditions:
- Osteoporosis (269,854 reports)
- Enlarged heart (18,848 reports)
COVID vaccines that are related to Enlarged heart:
- Enlarged heart in Moderna COVID Vaccine
- Enlarged heart in Pfizer BioNTech Covid Vaccine
- Enlarged heart in Johnson and Johnson Covid Vaccine
Common drugs associated with Enlarged heart:
- Aspirin: 1,837 reports
- Furosemide: 1,687 reports
- Lasix: 1,608 reports
- Vioxx: 1,475 reports
- Prednisone: 1,444 reports
- Zometa: 1,418 reports
- Digoxin: 1,054 reports
- Lipitor: 1,019 reports
- Lisinopril: 995 reports
- Coumadin: 942 reports
All the drugs that are associated with Enlarged heart:
- Enlarged heart (2,401 drugs)
Common conditions associated with Enlarged heart:
- High blood pressure: 1,330 reports
- Depression: 1,105 reports
- Multiple myeloma: 728 reports
- Pain: 727 reports
- Diabetes: 722 reports
- Rheumatoid arthritis: 706 reports
- Osteoporosis: 700 reports
All the conditions that are associated with Enlarged heart:
- Enlarged heart (1,611 conditions)
How the study uses the data?
The study is based on Enlarged heart and Osteoporosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Buspirone Hcl and Phoslo drug interaction - 6 seconds ago
- Loniten and Red Blood Cell Count Decreased - 6 seconds ago
- Ceftriaxone Sodium and Consciousness - Decreased - 10 seconds ago
- Varenicline Tartrate and Eosinophilic Fasciitis - 21 seconds ago
- Vitamin C and Atrial Fibrillation/Flutter - 21 seconds ago
- Octreotide Acetate and Neuralgia - 21 seconds ago
- Fatty Liver in Lamictal, how severe and when it was recovered? - 23 seconds ago
- Piperacillin And Tazobactam and Sucralfate drug interaction - 24 seconds ago
- Triaminic-12 vs. Doxylamine Succinate - 25 seconds ago
- Gabapentin and Chloromycetin drug interaction - 38 seconds ago